These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29483030)

  • 1. Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia.
    Armitage EP; Camara J; Bah S; Forster AS; Clarke E; Kampmann B; de Silva TI
    Vaccine; 2018 Mar; 36(13):1772-1780. PubMed ID: 29483030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR; Lone NI; Kavanagh K; Englishby T; Robertson C; McMenamin J; Wissman BV; Vasileiou E; Butler CC; Ritchie LD; Gunson R; Schwarze J; Sheikh A
    Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.
    Kwong JC; Pereira JA; Quach S; Pellizzari R; Dusome E; Russell ML; Hamid JS; Feinberg Y; Winter AL; Gubbay JB; Sirtonski B; Moher D; Sider D; Finkelstein M; Loeb M;
    Vaccine; 2015 Jan; 33(4):535-41. PubMed ID: 25488331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.
    Pitisuttithum P; Boonnak K; Chamnanchanunt S; Puthavathana P; Luvira V; Lerdsamran H; Kaewkungwal J; Lawpoolsri S; Thanachartwet V; Silachamroon U; Masamae W; Schuetz A; Wirachwong P; Thirapakpoomanunt S; Rudenko L; Sparrow E; Friede M; Kieny MP
    Lancet Infect Dis; 2017 Aug; 17(8):833-842. PubMed ID: 28533093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Feasibility Trial of Home Administration of Intranasal Vaccine by Parents to Eligible Children.
    Jhaveri R; Allyne K
    Clin Ther; 2017 Jan; 39(1):204-211.e4. PubMed ID: 27938896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
    Rudenko L; Kiseleva I; Krutikova E; Stepanova E; Rekstin A; Donina S; Pisareva M; Grigorieva E; Kryshen K; Muzhikyan A; Makarova M; Sparrow EG; Torelli G; Kieny MP
    PLoS One; 2018; 13(12):e0208028. PubMed ID: 30507951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial.
    Brooks WA; Zaman K; Lewis KD; Ortiz JR; Goswami D; Feser J; Sharmeen AT; Nahar K; Rahman M; Rahman MZ; Barin B; Yunus M; Fry AM; Bresee J; Azim T; Neuzil KM
    Lancet Glob Health; 2016 Dec; 4(12):e946-e954. PubMed ID: 27746226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.
    Krishnan A; Dar L; Saha S; Narayan VV; Kumar R; Kumar R; Amarchand R; Dhakad S; Chokker R; Choudekar A; Gopal G; Choudhary A; Potdar V; Chadha M; Lafond KE; Lindstrom S; Widdowson MA; Jain S
    PLoS Med; 2021 Apr; 18(4):e1003609. PubMed ID: 33914729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
    Nichol KL; Mendelman PM; Mallon KP; Jackson LA; Gorse GJ; Belshe RB; Glezen WP; Wittes J
    JAMA; 1999 Jul; 282(2):137-44. PubMed ID: 10411194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*.
    Sheldon EA; Jeanfreau R; Sliman JA; Charenkavanich S; Rousculp MD; Dubovsky F; Mallory RM
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1142-50. PubMed ID: 23061976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-existing influenza-specific nasal IgA or nasal viral infection does not affect live attenuated influenza vaccine immunogenicity in children.
    Cole ME; Kundu R; Abdulla AF; Andrews N; Hoschler K; Southern J; Jackson D; Miller E; Zambon M; Turner PJ; Tregoning JS
    Clin Exp Immunol; 2021 Apr; 204(1):125-133. PubMed ID: 33314126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized mucosal response to intranasal live attenuated influenza vaccine in adults.
    Barría MI; Garrido JL; Stein C; Scher E; Ge Y; Engel SM; Kraus TA; Banach D; Moran TM
    J Infect Dis; 2013 Jan; 207(1):115-24. PubMed ID: 23087433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults.
    Carter NJ; Curran MP
    Drugs; 2011 Aug; 71(12):1591-622. PubMed ID: 21861544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM; Yi T; Ambrose CS
    Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of live attenuated influenza vaccine on pneumococcal colonisation densities among children aged 24-59 months in The Gambia: a phase 4, open label, randomised, controlled trial.
    Peno C; Armitage EP; Clerc M; Balcazar Lopez C; Jagne YJ; Drammeh S; Jarju S; Sallah H; Senghore E; Lindsey BB; Camara J; Bah S; Mohammed NI; Dockrell DH; Kampmann B; Clarke E; Bogaert D; de Silva TI
    Lancet Microbe; 2021 Dec; 2(12):e656-e665. PubMed ID: 34881370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
    King JP; McLean HQ; Meece JK; Levine MZ; Spencer SM; Flannery B; Belongia EA
    Vaccine; 2018 Feb; 36(9):1214-1219. PubMed ID: 29395525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcus pyogenes Colonization in Children Aged 24-59 Months in the Gambia: Impact of Live Attenuated Influenza Vaccine and Associated Serological Responses.
    Keeley AJ; Groves D; Armitage EP; Senghore E; Jagne YJ; Sallah HJ; Drammeh S; Angyal A; Hornsby H; de Crombrugghe G; Smeesters PR; Rossi O; Carducci M; Peno C; Bogaert D; Kampmann B; Marks M; Shaw HA; Turner CR; de Silva TI
    J Infect Dis; 2023 Oct; 228(7):957-965. PubMed ID: 37246259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live versus attenuated influenza vaccine uptake and post-vaccination influenza-like illness outcomes in HIV-infected US Air Force members.
    Menegay JL; Xu X; Sunil TS; Okulicz JF
    J Clin Virol; 2017 Oct; 95():72-75. PubMed ID: 28889083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental acceptance of an intranasal vaccine: Example of influenza vaccine.
    Marien AG; Hochart A; Lagrée M; Diallo D; Martinot A; Dubos F
    Arch Pediatr; 2019 Feb; 26(2):71-74. PubMed ID: 30658873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.